Open AccessPotential Virus Involvement in Alzheimer’s Disease: Results from a Phase IIa Trial Evaluating Apovir, an Antiviral Drug Combination
Author(s) -
Nina Lindblom,
Lars Lindquist,
Jacob Westman,
Mikael Åström,
Roger Bullock,
Suzanne Hendrix,
LarsOlof Wahlund
Publication year - 2021
Publication title -
journal of alzheimer's disease reports
Language(s) - English
Resource type - Journals
ISSN - 2542-4823
DOI - 10.3233/adr-210301
Subject(s) - tolerability , medicine , placebo , adverse effect , clinical endpoint , clinical trial , drug , pharmacology , oncology , pathology , alternative medicine
Accumulating data suggest infectious agents are involved in Alzheimer's disease (AD). The two primary aims of this trial were to assess safety and efficacy of an antiviral drug combination on AD progression.